Leaflet CEQUA 0.9mg / ml ophthalmic drops single-dose solution

Product code:
W72203001
Indicated for:
immunosuppression
Route of administration:
ophthalmic
Substance:
cyclosporine (immunosuppressant)
ATC
S01XA18 — Sensory organs | Other ophthalmologicals
Cyclosporine is an immunosuppressant used to prevent organ rejection after transplantation and to treat autoimmune conditions such as rheumatoid arthritis or severe psoriasis. It works by inhibiting T-lymphocyte activity, reducing the immune response.

The medication is administered orally or intravenously, as directed by a doctor. It is important for patients to undergo regular check-ups to monitor kidney function and blood cyclosporine levels.

Patients should be aware of potential side effects, such as high blood pressure, kidney dysfunction, or infections. It is important to inform the doctor of any unusual symptoms.

Common side effects include high blood pressure, kidney dysfunction, tremors, and hypertrichosis. In rare cases, severe reactions such as liver toxicity or serious infections may occur. Patients should be informed of these risks before starting treatment.

General data about CEQUA 0.9mg / ml

Substance:
cyclosporine
Product code:
W72203001
Concentration:
0.9mg / ml
Pharmaceutical form:
ophthalmic drops single-dose solution
Product type:
Generic medicine
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer:
LABORATOIRE UNITHER - FRANTA
Holder:
TERAPIA S.A. - ROMANIA
Number:
16854/2026/01
Shelf life:
2 years-after packaging for sale;after the first opening a pungii - 5 days

Concentrations available for cyclosporine

  • 0.9mg/ml
  • 100mg
  • 100mg/ml
  • 10mg
  • 1mg/ml
  • 25mg
  • 50mg
  • 50mg/ml

Precautions:

Avoid grapefruit

Avoid grapefruit and grapefruit juice.

Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk

This medicine may increase the risk of infections.

Narrow therapeutic index

The dose must be followed strictly.

Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.